June 03, 2025

Niraparib Plus Abiraterone in HRR-Mutant Metastatic Castration-Sensitive Prostate Cancer

Results from the international phase III AMPLITUDE trial found that adding niraparib to abiraterone acetate plus prednisone significantly improved radiographic progression–free survival compared with ...

The ASCO Post

May 28, 2025

NCCN Clinical Practice Guidelines in Oncology: 2025 Updates

The National Comprehensive Cancer Network (NCCN) released its first set of Clinical Practice Guidelines in Oncology (NCCN Guidelines®) in 1996, covering eight tumor types. Today, guidelines are availa...

The ASCO Post

May 28, 2025

Stem Cell Transplant May Not Be Necessary in First Remission for Patients With Mantle Cell Lymphoma and Undetectable MRD

Autologous stem cell transplantation (ASCT) does not improve survival outcomes for patients with mantle cell lymphoma who achieve a deep first complete remission with undetectable measurable residual ...

The ASCO Post

May 23, 2025

W. Kimryn Rathmell, MD, PhD, FASCO, Named CEO of OSUCCC-James

Following a comprehensive national search, W. Kimryn Rathmell, MD, PhD, FASCO, former Director of the National Cancer Institute (NCI), has accepted the role of Chief Executive Officer (CEO) of The Ohi...

The ASCO Post

May 23, 2025

The Legal Impacts on Oncology Care of Prohibiting Diversity, Equity, and Inclusion Efforts

In January 2025, the Trump Administration issued executive orders asserting opposition to diversity, equity, and inclusion (DEI) programs on the federal level and rescinding Biden Administration order...

The ASCO Post

May 20, 2025

A High Proportion of U.S. Adults Are Behind on Cancer Screenings

A new survey conducted by the American Cancer Society Cancer Action Network found that over one-third of U.S. adults are more than 1 year behind on their cancer screenings.

The ASCO Post

May 16, 2025

Retifanlimab-dlwr Approved for Anal Cancer

The FDA approved the PD-1–blocking monoclonal antibody in combination with carboplatin and paclitaxel for the first-line treatment of adults with inoperable locally recurrent or metastatic squamous ce...

The ASCO Post

May 09, 2025

Joint Clinical Practice Guideline Addresses Opioid Conversion for Patients With Cancer

Several medical organizations recently released a joint Clinical Practice Guideline to provide recommendations on opioid conversion in adults with cancer.1 ASCO, together with the Multinational Associ...

The ASCO Post

May 09, 2025

2024 Annual Report to the Nation on the Status of Cancer Finds Mortality Rates Continue to Decline

Overall deaths from cancer over the past 2 decades have steadily declined in both men and women in the United States, according to the 2024 Annual Report to the Nation on the Status of Cancer, which w...

The ASCO Post